Hearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study
Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first